Back to Top
Casirivimab Biosimilar - Research Grade
Casirivimab Biosimilar - Research Grade
Product Benefits:ichorbio’s casirivimab biosimilar for Research Use Only (RUO)
Target:SARS-CoV-2 Spike Protein
Size:ichorbio’s casirivimab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg
Isotype:Human IgG1-Kappa
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects SARS-CoV-2 Spike Protein.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration:
5mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Applications:Functional Assays
Application Notes:This biosimilar is strictly for research use only (RUO).
| Concentration | 7.91mg/ml |
|---|---|
| isotype | Human IgG1-Kappa |
| Host | CHO Cells |
Write Your Own Review
Who Viewed This Also Viewed
